Development and comparison of single FLT3-inhibitors to dual FLT3/TAF1-inhibitors as an anti-leukemic approach. Leigh RS, Kaynak BL, Ruskoaho H, Valimaki MJ, et al. PLoS One 2025;20:e0320443.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Leigh RS, Kaynak BL, Ruskoaho H, Valimaki MJ, et al. Development and comparison of single FLT3-inhibitors to dual FLT3/TAF1-inhibitors as an anti-leukemic approach. PLoS One 2025;20:e0320443.
PMID: 40153395